Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...

This month is our safety and pharmacovigilance focus, so pharmaphorum's Hannah Blake interviewed Amgen's Vice President of Global Regulatory Affairs and Safety, Alan Morrison, to find out Amgen's ...

Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP Helix Innovation Park. The celebration also included a ground-breaking ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.

Most of them focus on safety-net programs like Medicaid aimed at helping low-income Americans. Is that really necessary? Probably so, for the following reasons: Trump 2.0 includes two to three new ...

St. Barnabas Hospital, a safety-net institution in the Bronx, will also team up with Downtown Brooklyn-based startup Cityblock Health and Union Community Health Center in the Bronx to reduce ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

Top-line phase 2 results with Amgen's MariTide drug for obesity are ... this year that a 20% reduction – coupled with a good safety profile and less frequent dosing – would give the drug ...

Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the completion of its $550 million manufacturing plant in the town of Holly Springs ...